Kouroukis, C., Crump, M., MacDonald, D., Larouche, J., Stewart, D., Johnston, J., . . . Sehn, L. (2015). An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACT. Curr Oncol.
Styl cytowania ChicagoKouroukis, C.T., et al. "An Open-label Expanded-access Trial of Bendamustine in Patients With Rituximab-refractory Indolent Non-Hodgkin Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia: BEND-ACT." Curr Oncol 2015.
Styl cytowania MLAKouroukis, C.T., et al. "An Open-label Expanded-access Trial of Bendamustine in Patients With Rituximab-refractory Indolent Non-Hodgkin Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia: BEND-ACT." Curr Oncol 2015.